Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

LNAI

LNAI News

Newswire

15:37

Lunai Bioworks shares rise 17.59% intraday after achieving complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models.

09:54

Lunai Bioworks shares surge 11.02% intraday after receiving LOI for next-gen immune cell therapy showing complete regression of pancreatic tumors in preclinical models and AI-driven DCCT targeting low-survival cancers.

07:48

Lunai Bioworks secures LOI for tumor-regressing immune-cell therapy platform.

10:02

Lunai (LNAI) up more than 100% since Nov 7

02:01

Lunai Bioworks publishes breakthrough immunotherapy platform in Vaccines journal.

View More

About LNAI

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More